Global stocks steady on solid US data

New York

Global stocks were mixed Wednesday as markets digested solid US economic data and positive clinical research on the Oxford-AstraZeneca coronavirus vaccine. Both the Dow and S&P 500 edged higher after data showed stronger-than-expected private-sector hiring in January and accelerating growth in the US services sector. Analysts also cited clinical data showing the Oxford-AstraZeneca Covid-19 vaccine reduces virus transmission and is highly protective after a single dose. The market appears to have stabilized following last week’s volatility, which was brought on by a social media-driven surge in shares of GameStop, AMC Entertainment.—AFP

Previous articleAsian market rally stalls but vaccine, stimulus hope lend support
Next articleCommerzbank posts 2.9b euro loss on virus, restructuring woes